Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.110
+0.050 (2.43%)
At close: Aug 14, 2026, 4:00 PM EDT
2.140
+0.030 (1.42%)
After-hours: Aug 14, 2026, 4:10 PM EDT
Lipocine Revenue
Lipocine had revenue of $190.10K in the quarter ending June 30, 2026, a decrease of -69.48%. This brings the company's revenue in the last twelve months to $1.57M, up 409.37% year-over-year. In the year 2025, Lipocine had annual revenue of $1.98M, down -82.35%.
Revenue (ttm)
$1.57M
Revenue Growth
+409.37%
P/S Ratio
11.08
Revenue / Employee
$112,104
Employees
14
Market Cap
17.40M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.98M | -9.22M | -82.35% |
| Dec 31, 2024 | 11.20M | 8.13M | 264.67% |
| Dec 31, 2023 | 3.07M | 2.57M | 514.16% |
| Dec 31, 2022 | 500.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 164.99K | -263.04K | -61.45% |
| Dec 31, 2018 | 428.03K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | 7.71M | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
LPCN News
- 12 days ago - Lipocine reports Q2 EPS (32c) vs. (41c) last year - TheFly
- 12 days ago - Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 - PRNewsWire
- 12 days ago - Lipocine Quarterly report: Q2 2026 - Filings
- 12 days ago - Lipocine Earnings release: Q2 2026 - Filings
- 13 days ago - Lipocine Appoints Michael J. Grissinger to Board of Directors - PRNewsWire
- 2 months ago - Lipocine Transcript: KOL event - Transcripts
- 2 months ago - Lipocine Slides: KOL event - Filings
- 2 months ago - Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 - PRNewsWire